Papers
1
Total Citations
4
H-Index
1
About
Zhenwei Liu is a virology researcher whose work focuses on the development of innovative assays to study viral neutralization, particularly for human adenoviruses. His most notable contribution is the design of a sensitive, high-throughput flow cytometry-based assay for measuring antibody neutralization of human adenovirus type 3 (HAdV-3), a pathogen associated with respiratory and ocular infections. This method, published in 2020, offers a rapid and reliable alternative to traditional neutralization tests, enabling large-scale screening of neutralizing antibodies for vaccine and therapeutic development. With 4 citations, this work has already provided a foundational tool for researchers investigating adenovirus immunology and antiviral strategies. Liu’s expertise in flow cytometry and viral immunology positions him as a key contributor to advancing diagnostic and therapeutic approaches against adenoviral diseases. His assay’s efficiency and sensitivity highlight his commitment to bridging laboratory innovation with practical applications in infectious disease control.
Research Focus
Key Achievements
Top Papers
- 1